CL Cresco Labs Inc.
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy's brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.…
Industry Peers
Drug Manufacturers - Specialty & GenericKey Statistics
About Cresco Labs (CNSX: CL)
›
Cresco Labs (CNSX: CL) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 2,900 employees.
The shares were at 0.7200 CAD on 13 November 2026, down 61.7% over 52 weeks. Its 52-week range is 0.6800 CAD to 3.120 CAD: the price is 76.9% below the high and 5.9% above the low.
Its market capitalisation is 271.57M CAD.
Cresco Labs reports return on equity of -39.8%, an operating margin of 9.6% and revenue up 5.9% year over year.
Its debt exceeds its cash by 559.15M USD, a debt-to-equity ratio of 1.72. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 4 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 2.341 CAD is 225.1% above the current price. The next earnings report is expected on 4 March 2027.